Cellebrite CRO sells 12,562 shares at $11.24 avg

Cellebrite DI Ltd. (CLBT) reported that Global Chief Revenue Officer Marcus Jewell sold 12,562 ordinary shares on August 21, 2026.

Rhea-AI Filing Summary

Cellebrite DI Ltd. (CLBT) reported that Global Chief Revenue Officer Marcus Jewell sold 12,562 ordinary shares on August 21, 2026. The transaction was executed at a weighted average price of $11.2416 per share, from multiple trades between $11.16 and $11.30. According to the disclosure, these shares were originally granted as restricted stock units on November 15, 2023, and the disposition is associated with Jewell’s tax obligations related to RSU vesting. Following the sale, he directly holds 427,128 ordinary shares of Cellebrite.

Insider Trade Summary

Net Seller: 12,562 shares

Net Sell 1 txn

Insider Jewell Marcus

Role Global Chief Revenue Officer

Sold 12,562 shs ($141K)

Type	Security	Shares	Price	Value
Sale	Ordinary shares, par value NIS 0.00001 F1, F2	12,562	$11.2416	$141K

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 427,128 shares (Direct)

Footnotes (2)

1. F1. The shares reported as disposed herein were granted on November 15, 2023, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.16 to $11.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 12,562 shares Weighted average price per share: $11.2416 Sale price range: $11.16–$11.30 +2 more

5 metrics

Shares sold 12,562 shares Ordinary shares sold by Marcus Jewell on August 21, 2026

Weighted average price per share $11.2416 Average price for the 12,562 ordinary shares sold

Sale price range $11.16–$11.30 Price range of multiple transactions comprising the reported sale

Shares held after transaction 427,128 shares Direct ownership by Marcus Jewell following the sale

RSU grant date November 15, 2023 Date the RSUs underlying the disposed shares were granted

Key Terms

restricted stock units ("RSUs"), weighted average price, vesting, tax obligations

4 terms

restricted stock units ("RSUs") financial

"The shares reported as disposed herein were granted on November 15, 2023, in the form of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

vesting financial

"tax obligations of the reporting person associated with the vesting of the RSUs."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

tax obligations financial

"The disposition of shares is associated with tax obligations of the reporting person"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Marcus Jewell report for CLBT?

Marcus Jewell, Global Chief Revenue Officer of Cellebrite DI Ltd. (CLBT), reported selling 12,562 ordinary shares on August 21, 2026. The sale is described as related to tax obligations arising from the vesting of previously granted RSUs.

How many Cellebrite (CLBT) shares did Marcus Jewell sell and at what price?

Marcus Jewell sold 12,562 ordinary shares of CLBT at a weighted average price of $11.2416 per share. The filing states the shares were sold in multiple transactions at prices ranging from $11.16 to $11.30, inclusive.

How many CLBT shares does Marcus Jewell hold after this transaction?

After the reported sale, Marcus Jewell directly holds 427,128 ordinary shares of Cellebrite DI Ltd. (CLBT). This post-transaction holding figure is provided in the ownership column of the Form 4 filing.

Why did Marcus Jewell dispose of these CLBT shares?

The filing states that the disposed shares were originally granted as restricted stock units (RSUs) on November 15, 2023, and that the disposition is associated with tax obligations of Marcus Jewell related to the vesting of those RSUs.

Were Marcus Jewell’s CLBT share sales made under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not marked as affirming a plan, and there is no footnote stating that the trades were made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 04:11 PM EDT Accepted by SEC EDGAR 08/24/2026 - 04:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jewell Marcus

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global Chief Revenue Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares, par value NIS 0.00001	08/21/2026		S(1)		12,562	D	$11.2416(2)	427,128	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported as disposed herein were granted on November 15, 2023, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.16 to $11.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Marcus Jewell	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)